Stockreport

IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024 [Yahoo! Finance]

IN8bio, Inc.  (INAB) 
PDF The platform has demonstrated the ability to target cancer cells while sparing healthy tissue when both express the CAR-targeted antigens, which could be used for previ [Read more]